Oncolytics Biotech, Inc. (ONCY)
0.9054
-0.01
(-1.59%)
USD |
NASDAQ |
May 07, 16:00
0.90
-0.01
(-0.60%)
After-Hours: 20:00
Oncolytics Biotech Shareholders Equity (Quarterly) : -3.799M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Karyopharm Therapeutics, Inc. | -292.93M |
| Sensei Biotherapeutics, Inc. | 23.01M |
| Candel Therapeutics, Inc. | 51.92M |
| Tango Therapeutics, Inc. | 346.18M |
| Moderna, Inc. | 7.408B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.582M |
| Total Liabilities (Quarterly) | 11.38M |
| Debt to Equity Ratio | -0.1482 |
| Current Ratio | 1.122 |
| Net Debt Paydown Yield | 0.05% |